These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38703998)

  • 1. 4S-fluorination of ProB29 in insulin lispro slows fibril formation.
    Breunig SL; Chapman AM; LeBon J; Quijano JC; Ranasinghe M; Rawson J; Demeler B; Ku HT; Tirrell DA
    J Biol Chem; 2024 Jun; 300(6):107332. PubMed ID: 38703998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin lispro: its role in the treatment of diabetes mellitus.
    Campbell RK; Campbell LK; White JR
    Ann Pharmacother; 1996 Nov; 30(11):1263-71. PubMed ID: 8913409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of LysB28, ProB29-human insulin analog and regular human insulin in the correction of incidental hyperglycemia.
    Holleman F; van den Brand JJ; Hoven RA; van der Linden JM; van der Tweel I; Hoekstra JB; Erkelens DW
    Diabetes Care; 1996 Dec; 19(12):1426-9. PubMed ID: 8941477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacokinetics and pharmacodynamics of insulin lispro mixtures.
    Roach P; Woodworth JR
    Clin Pharmacokinet; 2002; 41(13):1043-57. PubMed ID: 12403642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid-Acting and Human Insulins: Hexamer Dissociation Kinetics upon Dilution of the Pharmaceutical Formulation.
    Gast K; Schüler A; Wolff M; Thalhammer A; Berchtold H; Nagel N; Lenherr G; Hauck G; Seckler R
    Pharm Res; 2017 Nov; 34(11):2270-2286. PubMed ID: 28762200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensive insulin therapy with insulin lispro in patients with type 1 diabetes reduces the frequency of hypoglycemic episodes.
    Pfützner A; Küstner E; Forst T; Schulze-Schleppinghoff B; Trautmann ME; Haslbeck M; Schatz H; Beyer J
    Exp Clin Endocrinol Diabetes; 1996; 104(1):25-30. PubMed ID: 8750567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin lispro: a review of its pharmacological properties and therapeutic use in the management of diabetes mellitus.
    Wilde MI; McTavish D
    Drugs; 1997 Oct; 54(4):597-614. PubMed ID: 9339963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photoacoustic imaging reveals mechanisms of rapid-acting insulin formulations dynamics at the injection site.
    Khadria A; Paavola CD; Maslov K; Valenzuela FA; Sperry AE; Cox AL; Cao R; Shi J; Brown-Augsburger PL; Lozano E; Blankenship RL; Majumdar R; Bradley SA; Beals JM; Oladipupo SS; Wang LV
    Mol Metab; 2022 Aug; 62():101522. PubMed ID: 35671972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is the value of faster acting prandial insulin? Focus on ultra rapid lispro.
    Heise T; Piras de Oliveira C; Juneja R; Ribeiro A; Chigutsa F; Blevins T
    Diabetes Obes Metab; 2022 Sep; 24(9):1689-1701. PubMed ID: 35593434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, controlled trial comparing insulin lispro with human soluble insulin in patients with Type 1 diabetes on intensified insulin therapy. The UK Trial Group.
    Gale EA
    Diabet Med; 2000 Mar; 17(3):209-14. PubMed ID: 10784225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of insulin lispro in combination with NPH human insulin twice per day in patients with insulin-dependent or non-insulin-dependent diabetes mellitus. Multicenter Insulin Lispro Study Group.
    Vignati L; Anderson JH; Iversen PW
    Clin Ther; 1997; 19(6):1408-21. PubMed ID: 9444449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [From the concept of fast acting analogs to the properties of the insulin Lispro].
    Selam JL
    Diabetes Metab; 1997 Sep; 23 Suppl 3():45-9. PubMed ID: 9410552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
    Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
    Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of the insulin analog lispro on nighttime blood glucose control in type 1 diabetic patients.
    Ahmed AB; Home PD
    Diabetes Care; 1998 Jan; 21(1):32-7. PubMed ID: 9538967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initiation and gradual intensification of premixed insulin lispro therapy versus Basal {+/-} mealtime insulin in patients with type 2 diabetes eating light breakfasts.
    Giugliano D; Tracz M; Shah S; Calle-Pascual A; Mistodie C; Duarte R; Sari R; Woo V; Jiletcovici AO; Deinhard J; Wille SA; Kiljanski J
    Diabetes Care; 2014 Feb; 37(2):372-80. PubMed ID: 24170763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged efficacy of short acting insulin Lispro in combination with human ultralente in insulin-dependent diabetes mellitus.
    Burge MR; Waters DL; Holcombe JH; Schade DS
    J Clin Endocrinol Metab; 1997 Mar; 82(3):920-4. PubMed ID: 9062507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of insulin lispro mix 25 with insulin lispro mix 50 as insulin starter in Chinese patients with type 2 diabetes mellitus (CLASSIFY study): Subgroup analysis of a Phase 4 open-label randomized trial.
    Su Q; Liu C; Zheng H; Zhu J; Li PF; Qian L; Yang WY
    J Diabetes; 2017 Jun; 9(6):575-585. PubMed ID: 27371341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved postprandial glycemic control in patients with type 2 diabetes from subcutaneous injection of insulin lispro with hyaluronidase.
    Hompesch M; Muchmore DB; Morrow L; Ludington E; Vaughn DE
    Diabetes Technol Ther; 2012 Mar; 14(3):218-24. PubMed ID: 22136324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, open-label, comparative, crossover trial on preference, efficacy, and safety profiles of lispro insulin u-100 versus concentrated lispro insulin u-200 in patients with type 2 diabetes mellitus: a possible contribution to greater treatment adherence.
    Gentile S; Fusco A; Colarusso S; Piscopo M; Improta MR; Corigliano M; Martedi E; Oliva D; Santorelli A; Simonetti R; Giammarco A; Colella C; Miretto L; D'Alessandro A; Russo V; Guarino G; Marino G; Corigliano G; Strollo F
    Expert Opin Drug Saf; 2018 May; 17(5):445-450. PubMed ID: 29564932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human insulin analogue insulin lispro.
    Koivisto VA
    Ann Med; 1998 Jun; 30(3):260-6. PubMed ID: 9677011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.